Skip to main content

letter

. 1991 Oct 5;303(6806):855. doi: 10.1136/bmj.303.6806.855-b

DMPA and bone density.

K Dalton, M J Dalton

PMCID: PMC1671129 PMID: 1834290

855

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Burnett C. C., Reddi A. H. Influence of estrogen and progesterone on matrix-induced endochondral bone formation. Calcif Tissue Int. 1983 Jul;35(4-5):609–614. doi: 10.1007/BF02405102. [DOI] [PubMed] [Google Scholar]
Cundy T., Evans M., Roberts H., Wattie D., Ames R., Reid I. R. Bone density in women receiving depot medroxyprogesterone acetate for contraception. BMJ. 1991 Jul 6;303(6793):13–16. doi: 10.1136/bmj.303.6793.13. [DOI] [PMC free article] [PubMed] [Google Scholar]
DMPA and bone density. BMJ. 1991 Aug 24;303(6800):467–468. [PMC free article] [PubMed] [Google Scholar]
Nillius S. J., Johansson E. D. Plasma levels of progesterone after vaginal, rectal, or intramuscular administration of progesterone. Am J Obstet Gynecol. 1971 Jun 15;110(4):470–477. [PubMed] [Google Scholar]
Prior J. C., Vigna Y. M., Schechter M. T., Burgess A. E. Spinal bone loss and ovulatory disturbances. N Engl J Med. 1990 Nov 1;323(18):1221–1227. doi: 10.1056/NEJM199011013231801. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES